FI862303A - Foerfarande foer framstaellning av cancer motverkande kinazolinderivater. - Google Patents

Foerfarande foer framstaellning av cancer motverkande kinazolinderivater. Download PDF

Info

Publication number
FI862303A
FI862303A FI862303A FI862303A FI862303A FI 862303 A FI862303 A FI 862303A FI 862303 A FI862303 A FI 862303A FI 862303 A FI862303 A FI 862303A FI 862303 A FI862303 A FI 862303A
Authority
FI
Finland
Prior art keywords
group
heteroatom
motverkande
kinazolinderivater
cancer
Prior art date
Application number
FI862303A
Other languages
English (en)
Finnish (fi)
Other versions
FI862303A0 (fi
Inventor
Ann Lesley Jackman
David Richard Newell
Terence Richard Jones
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of FI862303A0 publication Critical patent/FI862303A0/fi
Publication of FI862303A publication Critical patent/FI862303A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI862303A 1985-05-31 1986-05-30 Foerfarande foer framstaellning av cancer motverkande kinazolinderivater. FI862303A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858513754A GB8513754D0 (en) 1985-05-31 1985-05-31 Anti-cancer quinazoline derivatives

Publications (2)

Publication Number Publication Date
FI862303A0 FI862303A0 (fi) 1986-05-30
FI862303A true FI862303A (fi) 1986-12-01

Family

ID=10579966

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862303A FI862303A (fi) 1985-05-31 1986-05-30 Foerfarande foer framstaellning av cancer motverkande kinazolinderivater.

Country Status (17)

Country Link
US (1) US5236927A (xx)
EP (1) EP0204529B1 (xx)
JP (1) JPS61282368A (xx)
AT (1) ATE87621T1 (xx)
AU (1) AU592271B2 (xx)
DE (1) DE3688150T2 (xx)
DK (1) DK255786A (xx)
ES (1) ES8800911A1 (xx)
FI (1) FI862303A (xx)
GB (2) GB8513754D0 (xx)
GR (1) GR861418B (xx)
HU (1) HUT45512A (xx)
IL (1) IL78910A0 (xx)
NO (1) NO862170L (xx)
NZ (1) NZ216363A (xx)
PT (1) PT82682B (xx)
ZA (1) ZA864051B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
EP0365763A1 (en) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Antiproliferative cyclic compounds
US5286726A (en) * 1990-04-12 1994-02-15 The Regents Of The University Of Michigan Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9013615D0 (en) 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
GB9105771D0 (en) * 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
GB9205320D0 (en) * 1992-03-11 1992-04-22 Ici Plc Anti-tumour compounds
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
US7262058B2 (en) * 2001-03-09 2007-08-28 Nonda Katopodis Method for determining lipid associated sialoprotein in body fluids
PL376310A1 (en) * 2002-10-18 2005-12-27 Koninklijke Philips Electronics N.V. Method and system for metadata protection in tv-anytime
WO2004041755A2 (en) * 2002-11-04 2004-05-21 Nps Pharmaceuticals, Inc. Quinazolinone compounds as calcilytics
EP1915351A1 (en) * 2005-07-15 2008-04-30 Schering Corporation Quinazoline derivatives useful in cancer treatment
US20070032502A1 (en) * 2005-07-15 2007-02-08 Schering Corporation Quinazoline derivatives useful in cancer treatment
WO2008041118A2 (en) 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
UY31432A1 (es) 2007-10-26 2009-05-29 Compuestos de diarilhidantoina
EP3309151A1 (en) 2009-06-25 2018-04-18 Alkermes Pharma Ireland Limited Heterocyclic compounds for the treatment of neurological and psychological disorders
CA2798172C (en) * 2010-01-07 2017-11-21 Alkermes Pharma Ireland Limited Quaternary ammonium salt prodrugs
AU2011270701B2 (en) 2010-06-24 2015-05-14 Alkermes Pharma Ireland Limited Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
HRP20240285T1 (hr) 2011-03-18 2024-05-24 Alkermes Pharma Ireland Limited Farmaceutski pripravci koji sadrže sorbitan estere
NZ630643A (en) 2012-03-19 2017-08-25 Alkermes Pharma Ireland Ltd Pharmaceutical compositions comprising fatty acid esters
US9999670B2 (en) 2012-03-19 2018-06-19 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising benzyl alcohol
US9993556B2 (en) 2012-03-19 2018-06-12 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising fatty glycerol esters
WO2014080285A2 (en) 2012-09-19 2014-05-30 Alkermes Pharma Ireland Limited Pharmaceutical compositions having improved storage stability
BR112016021535A8 (pt) 2014-03-20 2021-07-20 Alkermes Pharma Ireland Ltd kit compreendendo formulações de aripiprazol tendo velocidades de injeção aumentadas útil para o tratamento de uma desordem do sistema nervoso central e uso
AU2019230014A1 (en) 2018-03-05 2020-09-17 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
WO2024028999A1 (ja) * 2022-08-03 2024-02-08 Ils株式会社 Ｎ－［４－メチルアミノベンゾイル］－ｌ－グルタミン酸ジエチルエステルの製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1021196A (en) * 1964-02-20 1966-03-02 Parke Davis & Co Novel amino acids and means for producing the same
US3471498A (en) * 1967-08-11 1969-10-07 Parke Davis & Co Certain n-p-((2,4-diamino-6-quinazolinyl)-methyl)benzoylamino acids
EP0031237B1 (en) * 1979-12-19 1984-10-17 National Research Development Corporation Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents

Also Published As

Publication number Publication date
EP0204529B1 (en) 1993-03-31
NO862170L (no) 1986-12-01
EP0204529A3 (en) 1987-11-19
JPS61282368A (ja) 1986-12-12
NZ216363A (en) 1989-07-27
ZA864051B (en) 1987-01-28
US5236927A (en) 1993-08-17
GB8513754D0 (en) 1985-07-03
PT82682A (en) 1986-06-01
GB2175903B (en) 1988-10-12
AU592271B2 (en) 1990-01-04
HUT45512A (en) 1988-07-28
EP0204529A2 (en) 1986-12-10
AU5822086A (en) 1986-12-04
FI862303A0 (fi) 1986-05-30
DK255786D0 (da) 1986-05-30
ATE87621T1 (de) 1993-04-15
DE3688150T2 (de) 1993-07-29
GB2175903A (en) 1986-12-10
ES8800911A1 (es) 1987-12-01
DE3688150D1 (de) 1993-05-06
GB8613184D0 (en) 1986-07-02
ES555548A0 (es) 1987-12-01
DK255786A (da) 1986-12-01
IL78910A0 (en) 1986-09-30
PT82682B (pt) 1988-03-03
GR861418B (en) 1986-09-26

Similar Documents

Publication Publication Date Title
FI862303A (fi) Foerfarande foer framstaellning av cancer motverkande kinazolinderivater.
MX166257B (es) Composicion de revestimiento que contiene grupos de carbamato de hidroxialquilo
DK345989D0 (da) Quinolinderivater
DE3772015D1 (de) Chinolinverbindung.
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
DE69001495D1 (de) Dioxaphosphorin-verbindungen und damit stabilisierte polyolefin-zusammensetzungen.
MX170732B (es) Composicion de derivados de succinimida y su uso
ATE142620T1 (de) 1-alkyl-2-acyl-1,2-disulfonylhydrazine mit antineoplastischer aktivität
DE3688128D1 (de) Isoindolinderivate und verfahren zu ihrer herstellung.
NO863647D0 (no) Propanolderivater.
SU1690242A1 (ru) Антифидант
SU1266156A1 (ru) 7-морфолинокумарины в качестве красителей для лазерной техники

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: NATIONAL RESEARCH DEVELOPMENT